Intranasal epinephrine is a needle-free way to deliver the same drug used in traditional epinephrine autoinjectors, sprayed directly into the nose instead of injected into the thigh. The first product to reach the market, a nasal spray called neffy, gained FDA approval and offers a compact, single-use device that requires no needles at all. Clinical trials consistently show that epinephrine absorbed through the nasal lining produces blood pressure and heart rate responses comparable to those from intramuscular injection, making it a genuine alternative for treating severe allergic reactions including anaphylaxis.
Why a Needle-Free Option Matters
Epinephrine autoinjectors have been the standard emergency treatment for anaphylaxis for decades, yet many people who carry them hesitate to use them when it counts. Needle phobia is one big reason. Estimates suggest that roughly two out of three children and one in four adults experience some degree of needle fear, and social media analysis has found that the majority of popular videos about autoinjectors feature visible fearfulness about the device or include trigger warnings for needle phobia.1Annals of Allergy, Asthma & Immunology. P207 EXPLORING THE INTERPLAY OF EPINEPHRINE AND NEEDLE PHOBIA: IMPLICATIONS AND STRATEGIES That anxiety can translate into real-world delays. People wait too long, fumble with the device, or skip it entirely and hope the reaction passes on its own. A spray that goes into the nose rather than through the skin removes the needle from the equation entirely.
Beyond phobia, autoinjectors carry practical headaches. They are bulky enough that people sometimes leave them behind. They require correct thigh-injection technique, including holding the device in place for several seconds after firing. And they have a limited shelf life that, once expired, leaves the user without protection until a refill arrives. A small, pocketable nasal spray sidesteps several of these issues at once.
What Is Inside the Spray
The challenge with nasal delivery is that the lining of the nose was not designed to absorb large drug molecules quickly. Neffy solves this with a three-part formulation: epinephrine itself, an absorption enhancer called Intravail A3, and a single-use spray pump.2PubMed Central. Development of neffy, an Epinephrine Nasal Spray, for Severe Allergic Reactions The absorption enhancer temporarily loosens the tight junctions between cells in the nasal mucosa, allowing epinephrine to pass into the bloodstream faster than it otherwise would. All three components were already FDA-approved individually before being combined in the spray.
In practice, the device looks like a small nasal spray bottle. You insert the tip into one nostril, press the plunger, and inhale gently. There is no needle to uncap, no safety release to remove, and no injection site to massage afterward.
How Nasal Epinephrine Compares to Injections
The central question for any alternative to an autoinjector is whether it gets enough epinephrine into the blood, fast enough, to reverse an allergic emergency. The answer from clinical pharmacology studies is nuanced but reassuring. An integrated analysis of data from 175 participants found that the peak epinephrine concentration after a 1 mg nasal spray was roughly comparable to a manual intramuscular injection, though somewhat lower than autoinjector products like EpiPen. Despite that lower peak, the spray produced equivalent or even more pronounced effects on blood pressure, the physiological marker that matters most during anaphylaxis.3PubMed. Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: An integrated analysis
This gap between blood levels and actual body response is worth pausing on. A drug’s concentration in your bloodstream is not the same thing as what it does in your body. Nasal delivery appears to activate the receptors that tighten blood vessels and open airways with an efficiency that partly compensates for a modestly lower peak drug level. A separate study in healthy adults confirmed that the effects on heart rate and blood pressure were similar in pattern and magnitude across nasal spray and intramuscular injection groups.4PubMed. Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults Increases in pulse rate and blood pressure have been documented within one minute of nasal administration, confirming rapid receptor activation.5PubMed Central. Evaluating the Use of Nasal Epinephrine in Anaphylaxis: Current Status
Does Nasal Congestion Interfere
One of the first objections people raise is obvious: what if your nose is stuffed up? If you are already having an allergic reaction, there is a good chance your nasal passages are swollen. This turns out to be less of a problem than you might expect, and for a somewhat counterintuitive reason.
A randomized trial deliberately induced nasal congestion using an allergen challenge before administering the spray. Far from reducing absorption, congestion actually increased it. Participants with congested noses achieved peak epinephrine levels around 70% higher than those without congestion, and they reached those peaks faster. The likely explanation is that allergic inflammation makes the nasal lining more permeable and increases local blood flow, both of which speed drug absorption.6PubMed. Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestion So the very conditions that accompany anaphylaxis may actually help the nasal spray work better, not worse.
Absorption During Actual Anaphylaxis
The congestion finding raises a broader question: does anaphylaxis itself change how the spray performs? Studying this in humans during a genuine allergic emergency would be ethically difficult, but researchers have looked at it in an animal model. In anesthetized dogs experiencing induced anaphylaxis, nasal epinephrine reached roughly double the peak concentration compared to normal conditions, and overall drug exposure over the first 45 minutes was significantly higher during the allergic crisis.7PubMed Central. The impact of anaphylaxis on the absorption of intranasal epinephrine in anaesthetized non-naive beagle dogs The increase was most dramatic at early time points, exactly when you need the drug to hit hardest. This suggests that the physiological chaos of anaphylaxis, including the widened blood vessels and increased blood flow to mucosal surfaces, may enhance rather than hinder nasal absorption.
Animal data always comes with caveats, and dog nasal anatomy differs from ours. Still, the direction of the finding aligns with the human congestion data and provides some confidence that the spray will not fail precisely when it is most needed.
Use in Children and Adolescents
Food allergies are most common in children, and children are also the population least likely to tolerate needles calmly. Pediatric pharmacology data for intranasal epinephrine is encouraging. In children and adolescents, a 1 mg dose produced peak blood levels around 253 pg/mL, while a 2 mg dose reached roughly 540 pg/mL, showing that absorption scales predictably with the dose given.8Journal of Allergy and Clinical Immunology. Pharmacokinetics and Safety Profile of Intranasal Epinephrine in Children and Adolescents Both doses were well tolerated, with only one moderate side effect (nasal discomfort) reported across the trial.
Interestingly, children tend to achieve higher peak drug concentrations from the same dose compared to adults. A study directly comparing pediatric and adult subjects found that the 1 mg spray produced peak levels of about 651 pg/mL in children versus 481 pg/mL in adults. The blood pressure increase, however, was smaller in children than in adults, while the heart rate effect was similar across age groups.9PubMed. Pharmacokinetics and Pharmacodynamics of neffy, Epinephrine Nasal Spray, in Pediatric Allergy Patients Narrative reviews of the pediatric evidence base have described intranasal epinephrine as an easy-to-use, effective, and well-tolerated treatment option for severe allergic reactions in this age group.10PubMed Central. Epinephrine nasal spray for the treatment of anaphylaxis: perspectives in pediatrics
Side Effects
The side-effect profile of intranasal epinephrine largely mirrors what you would expect from epinephrine delivered any other way, plus some local nasal effects. The most common complaint is irritation inside the nose. After a second dose, some people also report headaches, nervousness, and tremor.11PubMed Central. Adrenaline nasal spray in emergency management: An initial expert opinion These are all recognized effects of epinephrine itself, not unique to the nasal route. In clinical trials evaluating repeated dosing or use in specific allergic conditions, only minor adverse events have been reported.12PubMed. Efficacy of Epinephrine Nasal Spray in the Treatment of Urticaria
Nothing in the published safety data suggests that nasal delivery introduces new or unexpected risks beyond the well-understood cardiovascular stimulation that epinephrine always produces. The local nasal discomfort tends to be mild and short-lived.
Repeat Dosing and Which Nostril to Use
Severe anaphylaxis sometimes requires a second dose of epinephrine. With autoinjectors, you carry a spare pen and inject again in the opposite thigh. With a nasal spray, the question becomes: same nostril or the other one?
A trial testing this found that spraying the second dose into the same nostril as the first produced substantially higher and more sustained blood levels than alternating nostrils. Two doses in the same nostril yielded a mean peak concentration of about 852 pg/mL compared to 581 pg/mL when nostrils were alternated and 495 pg/mL for intramuscular injection. The same-nostril approach also resulted in higher drug exposure through 45 minutes after dosing.13The Journal of Allergy and Clinical Immunology: In Practice. Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy (Epinephrine Nasal Spray) Versus Intramuscular Injection During Induced Allergic Rhinitis The finding makes pharmacological sense: the first dose of epinephrine constricts local blood vessels in that nostril, but the absorption enhancer is already working there, and the tissue is primed to continue absorbing drug. Switching to a fresh nostril means starting the absorption process from scratch.
How Easy Is It to Use Correctly
A device that sits in a drawer because nobody knows how to use it properly is not much help during an emergency. This is where nasal epinephrine may offer its most straightforward advantage over autoinjectors.
In human factors testing, every participant across multiple validation studies successfully administered both single and repeated doses from the nasal spray device using only the device itself and a quick reference guide, with no prior training. The studies included adolescents and untrained bystanders, populations that would realistically be the ones using the device in a real emergency.14Annals of Allergy, Asthma & Immunology. Successful administration of neffy (epinephrine nasal spray) by patients and caregivers – Five human factor studies
A separate study compared trainee teachers using a nasal device versus an intramuscular autoinjector in simulated anaphylaxis scenarios. Every participant completed the nasal device correctly, compared to about 71% for the autoinjector. The failure points with the injector were specific and telling: only about 20% of participants successfully held the autoinjector in place for the required time and massaged the injection site afterward. Administration time was also significantly shorter with the nasal route.15Allergologia et Immunopathologia. Administration of adrenaline by trainee teachers in a simulated anaphylactic reaction: intramuscular versus intranasal use These are not highly trained medical professionals. They are the people most likely to be present when a child in a school cafeteria has an allergic reaction.
Cost and Value Considerations
A new drug delivery platform inevitably raises the question of cost. A health economic analysis modeled various scenarios for peanut allergy and found that substituting a single nasal spray device for one of the two autoinjectors typically prescribed was cost-effective. In the base case, intranasal epinephrine was the more cost-effective option at only a marginal annual cost difference of about four dollars. However, adding a nasal spray on top of existing autoinjector prescriptions as a supplemental device was not cost-effective, even when the model assumed substantially reduced fatality risk from carrying more devices.16PubMed. A health economic analysis of noninjectable epinephrine compared with intramuscular epinephrine
Separate modeling has explored the quality-of-life dimension, attempting to quantify the daily psychological burden of carrying a needle-based device for people with needle aversion. When those quality-of-life decrements are factored in, the value proposition for a needle-free alternative increases.17Journal of Allergy and Clinical Immunology. Cost-effectiveness and Quality-of-Life Impacts of Needle-Free Intranasal Epinephrine for Anaphylaxis The economic case for nasal epinephrine, in other words, depends heavily on how much weight you give to the anxiety and compliance problems that needles create.
Other Needle-Free Approaches in Development
Neffy is the first intranasal product to reach the market, but it is not the only needle-free epinephrine concept being tested. A dry-powder nasal spray called FMXIN002 has shown some striking pharmacokinetic results. In a trial that deliberately induced nasal congestion with an allergen challenge before dosing, the powder formulation reached measurable blood levels within about one minute and achieved peak concentrations roughly double those of EpiPen.18PubMed. Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis The extremely fast onset is intriguing, though the differences were not statistically significant given the small study size. A dry powder could have advantages in stability and shelf life over a liquid formulation, though more data is needed.
Beyond nasal routes, researchers have also tested sublingual epinephrine films that dissolve under the tongue. Early human data from multiple non-injectable approaches suggest pharmacokinetic results comparable to the standard 0.3 mg autoinjector dose and manual intramuscular syringe injection.19PubMed. Innovations in the treatment of anaphylaxis: A review of recent data Reviews of this broader landscape of alternatives have concluded that non-injectable routes can achieve epinephrine levels on par with intramuscular delivery.20Current Opinion in Allergy and Clinical Immunology. Advances in the treatment of anaphylaxis: intranasal and sublingual versus intramuscular epinephrine The field is moving decisively toward giving patients options beyond needles, and the next few years will likely bring additional approved products.
Practical Scenarios Where the Nasal Route Changes the Calculus
There are situations where a nasal spray is not just a preference but a genuinely different capability. Consider someone exercising outdoors who goes into anaphylaxis from a bee sting. An autoinjector requires stopping, accessing the device, possibly removing clothing to reach the thigh, uncapping, injecting, and holding. A nasal spray requires one hand and one nostril. For a bystander who has never used an autoinjector and is watching someone swell up, the learning curve difference documented in usability studies is stark.
Schools are another important setting. Many districts require anaphylaxis action plans on file, but staff turnover means the person responding may never have practiced with an autoinjector. The near-perfect success rate of untrained users with nasal devices suggests that stocking a spray alongside or instead of an autoinjector could meaningfully reduce the delay between symptom onset and treatment. And for the child who has been refusing to carry an autoinjector because of the needle, a small spray that fits in a pocket and causes no injection pain removes what was, for them, the main barrier to having emergency medication available at all.